Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Change in Receivables (2020 - 2024)

Revolution Medicines (RVMD) posted Change in Receivables of -$1.3 million for Q1 2024, down 232.7% on a QoQ basis from $945000.0 in Q4 2023, and down 84.96% year-over-year from -$8.3 million in Q2 2023.

Analysis

Revolution Medicines (RVMD) Change in Receivables (2020 - 2024) Analysis & Trends

Revolution Medicines has reported Change in Receivables for 5 years, with the latest figure at -$1.3 million in Q1 2024.

  • On a quarterly basis, Change in Receivables fell 84.96% year-over-year to -$1.3 million in Q1 2024; TTM through Dec 2024 was -$1.3 million, a 63.32% increase from a year earlier, with the FY2024 full-year figure at -$1.3 million, up 63.32% from the prior year.
  • Change in Receivables was -$1.3 million for Q1 2024 at Revolution Medicines, down from $945000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $2.0 million in Q3 2020, with the low at -$2.9 million in Q4 2020.
  • Average Change in Receivables over 5 years is -$513941.2, with a median of -$678000.0 recorded in 2023.
  • The sharpest annual moves came in 2021 and 2023: Change in Receivables jumped 508.01% in 2021, then sank 716.18% in 2023.
  • Over 5 years, Change in Receivables stood at -$2.9 million in 2020, then soared by 48.97% to -$1.5 million in 2021, then soared by 82.0% to -$267000.0 in 2022, then surged by 453.93% to $945000.0 in 2023, then tumbled by 232.7% to -$1.3 million in 2024.
  • The last three Change in Receivables figures came in at -$1.3 million (Q1 2024), $945000.0 (Q4 2023), and -$2.2 million (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 1.35 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 1.37 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 333.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 140.20 Mn
10 Revolution Medicines 40.86 Bn 40.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -1.25 Mn
Dec 31, 2023 945,000.00
Sep 30, 2023 -2.20 Mn
Jun 30, 2023 -1.49 Mn
Mar 31, 2023 -678,000.00
Dec 31, 2022 -267,000.00
Sep 30, 2022 -684,000.00
Jun 30, 2022 241,000.00
Mar 31, 2022 -546,000.00
Dec 31, 2021 -1.48 Mn
Sep 30, 2021 885,000.00
Jun 30, 2021 -1.04 Mn
Mar 31, 2021 1.17 Mn
Dec 31, 2020 -2.91 Mn
Sep 30, 2020 1.97 Mn
Jun 30, 2020 -1.12 Mn
Mar 31, 2020 -287,000.00
API Access

Revolution Medicines Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RVMD&period=max&api_key=YOUR_API_KEY